197 related articles for article (PubMed ID: 36680067)
1. High Drug Resistance Levels Compromise the Control of HIV Infection in Pediatric and Adult Populations in Bata, Equatorial Guinea.
Rodríguez-Galet A; Ventosa-Cubillo J; Bendomo V; Eyene M; Mikue-Owono T; Nzang J; Ncogo P; Gonzalez-Alba JM; Benito A; Holguín Á
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680067
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Variants and Drug Resistance in Pregnant Women from Bata (Equatorial Guinea): 2012-2013.
Alvarez P; Fernández McPhee C; Prieto L; Martín L; Obiang J; Avedillo P; Vargas A; Rojo P; Benito A; Ramos JT; Holguín Á
PLoS One; 2016; 11(10):e0165333. PubMed ID: 27798676
[TBL] [Abstract][Full Text] [Related]
3. High drug resistance levels could compromise the control of HIV infection in paediatric and adolescent population in Kinshasa, the Democratic Republic of Congo.
Rubio-Garrido M; Reina G; Ndarabu A; Rodriguez-Galet A; Valadés-Alcaraz A; Barquín D; Carlos S; Holguín Á
PLoS One; 2021; 16(4):e0248835. PubMed ID: 33857166
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
[TBL] [Abstract][Full Text] [Related]
6. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
[TBL] [Abstract][Full Text] [Related]
7. The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study.
Lippman SA; Mooney AC; Puren A; Hunt G; Grignon JS; Prach LM; Gilmore HJ; Truong HM; Barnhart S; Liegler T
BMC Infect Dis; 2020 Mar; 20(1):248. PubMed ID: 32216752
[TBL] [Abstract][Full Text] [Related]
8. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance in children and adolescents with HIV in Panama.
Ventosa-Cubillo J; Pinzón R; González-Alba JM; Estripeaut D; Navarro ML; Holguín Á
J Antimicrob Chemother; 2023 Feb; 78(2):423-435. PubMed ID: 36454248
[TBL] [Abstract][Full Text] [Related]
10. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.
Rojas Sánchez P; Domínguez S; Jiménez De Ory S; Prieto L; Rojo P; Mellado P; Navarro M; Delgado R; Ramos JT; Holguín Á;
Pediatr Infect Dis J; 2018 Mar; 37(3):e48-e57. PubMed ID: 28991889
[TBL] [Abstract][Full Text] [Related]
11. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
[TBL] [Abstract][Full Text] [Related]
12. HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019-2021.
Sivay MV; Maksimenko LV; Nalimova TM; Nefedova AA; Osipova IP; Kriklivaya NP; Gashnikova MP; Ekushov VE; Totmenin AV; Kapustin DV; Pozdnyakova LL; Skudarnov SE; Ostapova TS; Yaschenko SV; Nazarova OI; Shevchenko VV; Ilyina EA; Novikova OA; Agafonov AP; Gashnikova NM
Int J Antimicrob Agents; 2024 Feb; 63(2):107074. PubMed ID: 38154660
[TBL] [Abstract][Full Text] [Related]
13. Emergence of HIV-1 drug resistance mutations among children and adolescents undergoing prolonged antiretroviral therapy in Guangxi.
Pang X; Lu H; He Q; Tang K; Ma J; Chen S; Huang J; Fang N; Xie H; Lan G; Liang S
J Glob Antimicrob Resist; 2024 Jun; 37():208-213. PubMed ID: 38608935
[TBL] [Abstract][Full Text] [Related]
14. High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.
Bwire GM; Aiko BG; Mosha IH; Kilapilo MS; Mangara A; Kazonda P; Swai JP; Swalehe O; Jordan MR; Vercauteren J; Sando D; Temba D; Shao A; Mauka W; Decouttere C; Vandaele N; Sangeda RZ; Killewo J; Vandamme AM
Sci Rep; 2023 Nov; 13(1):20493. PubMed ID: 37993493
[TBL] [Abstract][Full Text] [Related]
15. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
Bareng OT; Moyo S; Zahralban-Steele M; Maruapula D; Ditlhako T; Mokaleng B; Mokgethi P; Choga WT; Moraka NO; Pretorius-Holme M; Mine MO; Raizes E; Molebatsi K; Motswaledi MS; Gobe I; Mohammed T; Gaolathe T; Shapiro R; Mmalane M; Makhema JM; Lockman S; Essex M; Novitsky V; Gaseitsiwe S
J Antimicrob Chemother; 2022 Apr; 77(5):1385-1395. PubMed ID: 35229102
[TBL] [Abstract][Full Text] [Related]
17. HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania.
Rugemalila J; Kamori D; Kunambi P; Mizinduko M; Sabasaba A; Masoud S; Msafiri F; Mugusi S; Mutagonda R; Mlunde L; Amani D; Mboya E; Mahiti M; Ruhago G; Mushi J; Sambu V; Mgomella G; Jullu B; Maokola W; Njau P; Mutayoba B; Barabona G; Ueno T; Pembe A; Nagu T; Sunguya B; Aboud S
PLoS One; 2023; 18(2):e0281528. PubMed ID: 36821538
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
Crowell TA; Danboise B; Parikh A; Esber A; Dear N; Coakley P; Kasembeli A; Maswai J; Khamadi S; Bahemana E; Iroezindu M; Kiweewa F; Owuoth J; Freeman J; Jagodzinski LL; Malia JA; Eller LA; Tovanabutra S; Peel SA; Ake JA; Polyak CS;
Clin Infect Dis; 2021 Oct; 73(7):e2311-e2322. PubMed ID: 32785695
[TBL] [Abstract][Full Text] [Related]
20. Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.
Soldi GFR; Ribeiro IC; Ahagon CM; Coelho LPO; Cabral GB; Lopes GISL; Ferreira JLP; Brígido LFM;
PLoS One; 2019; 14(10):e0223210. PubMed ID: 31574109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
